Callan JMB, Inc. (CJMB)
NASDAQ:CJMB
Want to see CJMB full AI Analyst Report?
Top Page
Callan JMB, Inc.
(NASDAQ:CJMB)
Select Model
Select Model
Rating:43Neutral
Price Target:
$0.93
▼(-36.14% Downside)
Action:ReiteratedDate:04/11/26
The score is primarily constrained by deteriorating financial performance (sharp revenue decline, large losses, and 2025 cash burn) and bearish technicals (price below key moving averages with negative MACD). A Nasdaq equity deficiency notice adds material downside risk, while valuation offers limited support due to negative earnings and no dividend yield data.
Positive Factors
Gross margin resilience
Gross margin holding in the high-30% range despite revenue loss indicates the core pricing and cost structure remains intact. That durable unit economics mean the company can potentially restore profitability by cutting operating spend or regaining volume without rebuilding product-level margins.
Negative Factors
Sharp revenue decline
A multi-year collapse in revenue erodes scale and operating leverage. Losing roughly three-quarters of top-line over 2022–2025 weakens competitive position, inflates per-unit overhead, and makes restoration of prior profit levels far more difficult absent clear new demand or structural cost transformation.
Read all positive and negative factors
Positive Factors
Negative Factors
Gross margin resilience
Gross margin holding in the high-30% range despite revenue loss indicates the core pricing and cost structure remains intact. That durable unit economics mean the company can potentially restore profitability by cutting operating spend or regaining volume without rebuilding product-level margins.
Read all positive factors
Callan JMB, Inc. (CJMB) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$5.63M
Dividend YieldN/A
Average Volume (3M)10.79K
Price to Earnings (P/E)―
Beta (1Y)0.25
Revenue GrowthN/A
EPS GrowthN/A
CountryUS
Employees26
SectorReal Estate
Sector Strength53
IndustryIntegrated Freight & Logistics
Share Statistics
EPS (TTM)N/A
Shares Outstanding5,627,368
10 Day Avg. Volume12,214
30 Day Avg. Volume10,793
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)2.09
Price to Sales (P/S)0.85
P/FCF Ratio-0.94
Enterprise Value/Market Cap0.76
Enterprise Value/Revenue0.74
Enterprise Value/Gross Profit2.02
Enterprise Value/Ebitda-0.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Callan JMB, Inc. Business Overview & Revenue Model
Company Description
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry. It offers logistics solutions and services utilized for frozen shipping in the life sciences...
Callan JMB, Inc. Financial Statement Overview
Summary
Income Statement
24
Negative
Balance Sheet
38
Negative
Cash Flow
20
Very Negative
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
Income Statement | ||||
| Total Revenue | 5.72M | 6.56M | 13.20M | 22.77M |
| Gross Profit | 2.10M | 2.56M | 5.65M | 9.45M |
| EBITDA | -7.81M | -2.12M | 2.30M | 6.37M |
| Net Income | -7.97M | -2.29M | 2.18M | 6.22M |
Balance Sheet | ||||
| Total Assets | 5.78M | 5.08M | 9.71M | 15.25M |
| Cash, Cash Equivalents and Short-Term Investments | 2.13M | 2.10M | 5.16M | 6.19M |
| Total Debt | 2.00M | 907.45K | 400.00K | 410.88K |
| Total Liabilities | 3.45M | 1.91M | 910.27K | 1.24M |
| Stockholders Equity | 2.33M | 3.17M | 8.80M | 14.01M |
Cash Flow | ||||
| Free Cash Flow | -5.16M | 494.19K | 6.51M | 8.94M |
| Operating Cash Flow | -4.55M | 540.35K | 7.00M | 9.36M |
| Investing Cash Flow | -616.90K | -46.17K | -490.02K | -422.49K |
| Financing Cash Flow | 5.20M | -3.55M | -7.54M | -4.57M |
Callan JMB, Inc. Technical Analysis
Negative
1.45
Price Trends
4.34
Negative
4.65
Negative
Market Momentum
-0.26
Positive
29.52
Positive
25.52
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CJMB, the sentiment is Negative. The current price of 1.45 is below the 20-day moving average (MA) of 3.85, below the 50-day MA of 4.34, and equal to the 200-day MA of ―, indicating a neutral trend. The MACD of -0.26 indicates Positive momentum. The RSI at 29.52 is Positive, neither overbought nor oversold. The STOCH value of 25.52 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CJMB.
Callan JMB, Inc. Risk Analysis
Callan JMB, Inc. disclosed 45 risk factors in its most recent earnings report. Callan JMB, Inc. reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Callan JMB, Inc. Peers Comparison
UnderperformOutperform
Sector (65)
CJMB
Callan JMB, Inc.
1.00
-4.25
-80.95%
SGLY
Singularity Future Technology
0.44
-0.51
-53.64%
ATXG
Addentax Group
5.05
-6.73
-57.12%
PSIG
PS International Group
6.31
2.95
87.80%
GVH
Globavend Holdings Ltd.
3.74
-97.46
-96.30%
NCEW
New Century Logistics (BVI) Ltd.
16.40
-1.20
-6.82%
Callan JMB, Inc. Corporate Events
Delistings and Listing ChangesRegulatory Filings and Compliance
Callan JMB Receives Nasdaq Deficiency Notice on Equity
Negative
Apr 10, 2026
On April 7, 2026, Callan JMB Inc. received a deficiency notice from Nasdaq stating that the company was no longer in compliance with the exchange’s requirement to maintain at least $2.5 million in stockholders’ equity for continued lis...
Private Placements and FinancingRegulatory Filings and Compliance
Callan JMB Amends Equity Purchase Agreement with Hexstone
Neutral
Mar 12, 2026
On March 10, 2026, Callan JMB Inc. amended its existing common stock purchase agreement with Hexstone Capital, LLC, extending the maturity date to April 1, 2027 and revising key pricing and trading terms governing future stock sales. The regular p...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.